CRISPR/Cas9 technology generated an in-frame deletion of exons 3 and 4 that is predicted to encode a shortened N-terminal fragment lacking the CUB (the complement Clr/C1s, Uegf, Bmp1) and PTX (pentraxin) domains. (J:315981)
查看原文 参与反馈
CRISPR/Cas9 technology generated an in-frame deletion of exons 3 and 4 that is predicted to encode a shortened N-terminal fragment lacking the CUB (the complement Clr/C1s, Uegf, Bmp1) and PTX (pentraxin) domains. (J:315981)